Regeneron Stock Plunges 6.85% Amid Market Sell-Off

On April 29, 2025, Regeneron's stock experienced a significant drop of 6.85% in pre-market trading, reflecting investor concerns and market sentiment.

Regeneron Pharmaceuticals has been impacted by a broader market sell-off, with its stock price declining significantly this year. This trend has been observed across various sectors, indicating a general market downturn rather than company-specific issues.

Additionally, the resignation of Thomas Malley from the Board of Directors on January 22, 2024, has added to the uncertainty surrounding the company. Malley's decision to step down to focus on other commitments has raised questions about the company's leadership and strategic direction.